Chimeric antigen receptor-T-cell therapy: China leading the way

Bibliographic Details
Main Author: Robert Peter Gale
Format: Article
Language:English
Published: Wolters Kluwer Health 2022-07-01
Series:Blood Science
Online Access:http://journals.lww.com/10.1097/BS9.0000000000000118
_version_ 1797976938358243328
author Robert Peter Gale
author_facet Robert Peter Gale
author_sort Robert Peter Gale
collection DOAJ
first_indexed 2024-04-11T04:58:59Z
format Article
id doaj.art-9e82be5490034b6c9f9036590ba8e919
institution Directory Open Access Journal
issn 2543-6368
language English
last_indexed 2024-04-11T04:58:59Z
publishDate 2022-07-01
publisher Wolters Kluwer Health
record_format Article
series Blood Science
spelling doaj.art-9e82be5490034b6c9f9036590ba8e9192022-12-26T06:00:24ZengWolters Kluwer HealthBlood Science2543-63682022-07-014317617610.1097/BS9.0000000000000118202207000-00014Chimeric antigen receptor-T-cell therapy: China leading the wayRobert Peter Gale0a Imperial College of Science, Technology and Medicine, London, UKhttp://journals.lww.com/10.1097/BS9.0000000000000118
spellingShingle Robert Peter Gale
Chimeric antigen receptor-T-cell therapy: China leading the way
Blood Science
title Chimeric antigen receptor-T-cell therapy: China leading the way
title_full Chimeric antigen receptor-T-cell therapy: China leading the way
title_fullStr Chimeric antigen receptor-T-cell therapy: China leading the way
title_full_unstemmed Chimeric antigen receptor-T-cell therapy: China leading the way
title_short Chimeric antigen receptor-T-cell therapy: China leading the way
title_sort chimeric antigen receptor t cell therapy china leading the way
url http://journals.lww.com/10.1097/BS9.0000000000000118
work_keys_str_mv AT robertpetergale chimericantigenreceptortcelltherapychinaleadingtheway